| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| December 3rd, 2008 | 28 | Yes |
Popular Name: Flavopiridol Flavopiridol
Find On: PubMed — Wikipedia — Google
CAS Numbers: 131740-09-5 , 146426-40-6
(-)cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one
131740-09-5; Alvocidib hydrochloride (USAN); D02880
146426-40-6; Alvocidib (USAN/INN); D09868
2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE
2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one
2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one
HL-275; HMR-1275; L-86-8275; MDL-107826A; NSC-649890
HL-275; HMR-1275; L-868275; L-86-8275; MDL-107826A; NSC-649890
HL-275; HMR-1275; L86-8275; MDL-107826A; NSC-649890; L-86-8275
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.46 | 7.04 | -50.59 | 4 | 6 | 1 | 95 | 402.854 | 2 | ↓ |
| Hi High (pH 8-9.5) | 3.46 | 7.74 | -91.2 | 3 | 6 | 0 | 98 | 401.846 | 2 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 9.40e-02 g/l | DrugBank-experimental |
| Target | CDK | Selleck Chemicals |
| PUBCHEM_PATENT_ID | EP0150999A2; EP0150999B1; EP0167248A2; EP0167248B1; EP0170446A1; EP0170446B1; EP0222279A2; EP0244932A2; EP0257052A1; EP0338439A1; EP0338440A1; EP0343696A2; EP0395124A1; EP0874847A1; EP0888458A1; EP0912535A1; EP0914116A1; EP0914116B1; EP0919244A2; EP095538 | IBM Patent Data |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAK1-1-E | Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5300 | 0.26 | Binding ≤ 10μM |
| AAPK1-1-E | AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6600 | 0.26 | Binding ≤ 10μM |
| ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.29 | Binding ≤ 10μM |
| ALK-1-E | ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 670 | 0.31 | Binding ≤ 10μM |
| AVR2B-1-E | Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2400 | 0.28 | Binding ≤ 10μM |
| CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 70 | 0.36 | Binding ≤ 10μM |
| CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 70 | 0.36 | Binding ≤ 10μM |
| CCNB-1-E | G2/mitotic-specific Cyclin B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.32 | Binding ≤ 10μM |
| CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
| CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
| CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
| CCND1-1-E | G1/S-specific Cyclin D1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
| CCND2-1-E | G1/S-specific Cyclin D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
| CCND3-1-E | G1/S-specific Cyclin D3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
| CCNE1-1-E | G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 960 | 0.30 | Binding ≤ 10μM |
| CCNE2-1-E | G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 960 | 0.30 | Binding ≤ 10μM |
| CCNH-1-E | Cyclin H (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.32 | Binding ≤ 10μM |
| CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
| CDK14-1-E | Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.35 | Binding ≤ 10μM |
| CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 440 | 0.32 | Binding ≤ 10μM |
| CDK17-1-E | Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 480 | 0.32 | Binding ≤ 10μM |
| CDK18-1-E | Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
| CDK19-1-E | Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 57 | 0.36 | Binding ≤ 10μM |
| CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 960 | 0.30 | Binding ≤ 10μM |
| CDK3-1-E | Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 410 | 0.32 | Binding ≤ 10μM |
| CDK4-2-E | Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
| CDK5-1-E | Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 43 | 0.37 | Binding ≤ 10μM |
| CDK6-1-E | Cyclin-dependent Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 80 | 0.35 | Binding ≤ 10μM |
| CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 875 | 0.30 | Binding ≤ 10μM |
| CDK8-1-E | Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.35 | Binding ≤ 10μM |
| CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.41 | Binding ≤ 10μM |
| CLK1-1-E | Dual Specificty Protein Kinase CLK1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
| CLK2-1-E | Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
| CLK3-1-E | Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
| CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
| CTRO-1-E | Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.35 | Binding ≤ 10μM |
| DCLK1-1-E | Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.28 | Binding ≤ 10μM |
| DCLK3-1-E | Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
| DMPK-1-E | Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 650 | 0.31 | Binding ≤ 10μM |
| DYR1B-1-E | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 84 | 0.35 | Binding ≤ 10μM |
| E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
| EGFR-2-E | Epidermal Growth Factor Receptor ErbB1 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 7600 | 0.26 | Binding ≤ 10μM |
| EPHA2-1-E | Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.28 | Binding ≤ 10μM |
| EPHA3-1-E | Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3300 | 0.27 | Binding ≤ 10μM |
| EPHA5-1-E | Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.27 | Binding ≤ 10μM |
| EPHB1-1-E | Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
| FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6500 | 0.26 | Binding ≤ 10μM |
| GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 370 | 0.32 | Binding ≤ 10μM |
| GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1300 | 0.29 | Binding ≤ 10μM |
| GSK3B-7-E | Glycogen Synthase Kinase-3 Beta (cluster #7 Of 7), Eukaryotic | Eukaryotes | 730 | 0.31 | Binding ≤ 10μM |
| IKKE-1-E | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.28 | Binding ≤ 10μM |
| KCC2A-1-E | CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.29 | Binding ≤ 10μM |
| KCC2B-1-E | CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2600 | 0.28 | Binding ≤ 10μM |
| KCC4-1-E | CaM Kinase IV (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3200 | 0.27 | Binding ≤ 10μM |
| KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4600 | 0.27 | Binding ≤ 10μM |
| KKCC1-1-E | CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 79 | 0.36 | Binding ≤ 10μM |
| KKCC2-1-E | CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 430 | 0.32 | Binding ≤ 10μM |
| KPCA-1-E | Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
| KPCB-1-E | Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
| KPCD-1-E | Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 890 | 0.30 | Binding ≤ 10μM |
| KPCD1-1-E | Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
| KPCD2-1-E | Serine/threonine-protein Kinase D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
| KPCD3-1-E | Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 170 | 0.34 | Binding ≤ 10μM |
| KPCE-1-E | Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic | Eukaryotes | 480 | 0.32 | Binding ≤ 10μM |
| KPCG-1-E | Protein Kinase C Gamma (cluster #1 Of 4), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
| KPCI-1-E | Protein Kinase C Iota (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
| KPCL-2-E | Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic | Eukaryotes | 350 | 0.32 | Binding ≤ 10μM |
| KPCT-1-E | Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic | Eukaryotes | 350 | 0.32 | Binding ≤ 10μM |
| KPCZ-1-E | Protein Kinase C Zeta (cluster #1 Of 5), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
| KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 720 | 0.31 | Binding ≤ 10μM |
| KS6A2-1-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
| KS6A4-1-E | Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.29 | Binding ≤ 10μM |
| KS6A5-1-E | Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2000 | 0.28 | Binding ≤ 10μM |
| KS6A6-1-E | Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 800 | 0.30 | Binding ≤ 10μM |
| LTK-1-E | Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
| M3K10-1-E | Mitogen-activated Protein Kinase Kinase Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
| M3K9-1-E | Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5700 | 0.26 | Binding ≤ 10μM |
| M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3300 | 0.27 | Binding ≤ 10μM |
| M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.27 | Binding ≤ 10μM |
| MERTK-1-E | Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6800 | 0.26 | Binding ≤ 10μM |
| MK07-1-E | Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.31 | Binding ≤ 10μM |
| MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5500 | 0.26 | Binding ≤ 10μM |
| MK15-1-E | Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.32 | Binding ≤ 10μM |
| MKNK2-1-E | MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.27 | Binding ≤ 10μM |
| MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9500 | 0.25 | Binding ≤ 10μM |
| MRCKB-1-E | Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3300 | 0.27 | Binding ≤ 10μM |
| NUAK2-1-E | NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
| PHKG1-1-E | Phosphorylase Kinase Gamma Subunit 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
| PHKG2-1-E | Phosphorylase Kinase Gamma Subunit 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2900 | 0.28 | Binding ≤ 10μM |
| PIM1-1-E | Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 560 | 0.31 | Binding ≤ 10μM |
| PIM2-1-E | Serine/threonine-protein Kinase PIM2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 770 | 0.31 | Binding ≤ 10μM |
| PIM3-1-E | Serine/threonine-protein Kinase PIM3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 600 | 0.31 | Binding ≤ 10μM |
| PKN1-1-E | Protein Kinase N1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.27 | Binding ≤ 10μM |
| PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.28 | Binding ≤ 10μM |
| PYGM-2-E | Muscle Glycogen Phosphorylase (cluster #2 Of 4), Eukaryotic | Eukaryotes | 1000 | 0.30 | Binding ≤ 10μM |
| SRMS-1-E | Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
| ST17B-1-E | Serine/threonine-protein Kinase 17B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5100 | 0.26 | Binding ≤ 10μM |
| STK3-1-E | Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 9400 | 0.25 | Binding ≤ 10μM |
| STK33-1-E | Serine/threonine-protein Kinase 33 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.29 | Binding ≤ 10μM |
| TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5600 | 0.26 | Binding ≤ 10μM |
| TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 55 | 0.36 | Binding ≤ 10μM |
| UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.27 | Binding ≤ 10μM |
| Z104294-2-O | Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #2 Of 2), Other | Other | 170 | 0.34 | Binding ≤ 10μM |
| Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 90 | 0.35 | Binding ≤ 10μM |
| Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 100 | 0.35 | Binding ≤ 10μM |
| Z104296-1-O | Cyclin-dependent Kinase 1/cyclin B1 (cluster #1 Of 2), Other | Other | 30 | 0.38 | Binding ≤ 10μM |
| Z100090-1-O | ABAE (Fibroblast Cells) (cluster #1 Of 1), Other | Other | 45 | 0.37 | Functional ≤ 10μM |
| Z100091-1-O | HS27 (Fibroblast Cells) (cluster #1 Of 1), Other | Other | 51 | 0.36 | Functional ≤ 10μM |
| Z100093-1-O | LX-1 (Lung Carcinoma Cells) (cluster #1 Of 1), Other | Other | 75 | 0.36 | Functional ≤ 10μM |
| Z100094-1-O | MLF (Lung Fibroblast Cells) (cluster #1 Of 1), Other | Other | 72 | 0.36 | Functional ≤ 10μM |
| Z100095-1-O | MIP (Colon Carcinoma Cells) (cluster #1 Of 1), Other | Other | 120 | 0.35 | Functional ≤ 10μM |
| Z80054-1-O | Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other | Other | 86 | 0.35 | Functional ≤ 10μM |
| Z80064-1-O | CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other | Other | 52 | 0.36 | Functional ≤ 10μM |
| Z80156-2-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other | Other | 46 | 0.37 | Functional ≤ 10μM |
| Z80186-9-O | K562 (Erythroleukemia Cells) (cluster #9 Of 11), Other | Other | 130 | 0.34 | Functional ≤ 10μM |
| Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 66 | 0.36 | Functional ≤ 10μM |
| Z80354-4-O | OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other | Other | 54 | 0.36 | Functional ≤ 10μM |
| Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 66 | 0.36 | Functional ≤ 10μM |
| Z80475-1-O | SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other | Other | 77 | 0.36 | Functional ≤ 10μM |
| Z80675-1-O | AG1523 (Fibroblast Cells) (cluster #1 Of 1), Other | Other | 6700 | 0.26 | Functional ≤ 10μM |
| Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 96 | 0.35 | Functional ≤ 10μM |
| Z80852-2-O | A-431 (Epidermoid Carcinoma Cells) (cluster #2 Of 3), Other | Other | 75 | 0.36 | Functional ≤ 10μM |
| Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 490 | 0.32 | Functional ≤ 10μM |
| Z81034-1-O | A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other | Other | 78 | 0.36 | Functional ≤ 10μM |
| Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 16 | 0.39 | Functional ≤ 10μM |
| Z81186-1-O | LS174T (Colon Adencocarcinoma Cells) (cluster #1 Of 2), Other | Other | 65 | 0.36 | Functional ≤ 10μM |
| Z81225-1-O | M109 (Lung Carcinoma Cells) (cluster #1 Of 2), Other | Other | 80 | 0.35 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 670 | 0.31 | Binding ≤ 1μM |
| KKCC1_HUMAN | Q8N5S9 | CaM-kinase Kinase Alpha, Human | 19 | 0.39 | Binding ≤ 1μM |
| KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 320 | 0.32 | Binding ≤ 1μM |
| CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 57 | 0.36 | Binding ≤ 1μM |
| CDK8_HUMAN | P49336 | Cell Division Protein Kinase 8, Human | 120 | 0.35 | Binding ≤ 1μM |
| CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 110 | 0.35 | Binding ≤ 1μM |
| CCNA1_HUMAN | P78396 | Cyclin A1, Human | 50 | 0.37 | Binding ≤ 1μM |
| CCNA2_HUMAN | P20248 | Cyclin A2, Human | 50 | 0.37 | Binding ≤ 1μM |
| CCNH_HUMAN | P51946 | Cyclin H, Human | 400 | 0.32 | Binding ≤ 1μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 210 | 0.33 | Binding ≤ 1μM |
| Z104296 | Z104296 | Cyclin-dependent Kinase 1/cyclin B1 | 200 | 0.33 | Binding ≤ 1μM |
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 170 | 0.34 | Binding ≤ 1μM |
| CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 410 | 0.32 | Binding ≤ 1μM |
| CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 100 | 0.35 | Binding ≤ 1μM |
| Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 100 | 0.35 | Binding ≤ 1μM |
| CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 110 | 0.35 | Binding ≤ 1μM |
| Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 170 | 0.34 | Binding ≤ 1μM |
| CDK6_HUMAN | Q00534 | Cyclin-dependent Kinase 6, Human | 80 | 0.35 | Binding ≤ 1μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 23 | 0.38 | Binding ≤ 1μM |
| CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 20 | 0.38 | Binding ≤ 1μM |
| CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 1000 | 0.30 | Binding ≤ 1μM |
| DYR1B_HUMAN | Q9Y463 | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B, Human | 84 | 0.35 | Binding ≤ 1μM |
| CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 100 | 0.35 | Binding ≤ 1μM |
| CCND2_HUMAN | P30279 | G1/S-specific Cyclin D2, Human | 100 | 0.35 | Binding ≤ 1μM |
| CCND3_HUMAN | P30281 | G1/S-specific Cyclin D3, Human | 100 | 0.35 | Binding ≤ 1μM |
| CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 170 | 0.34 | Binding ≤ 1μM |
| CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 170 | 0.34 | Binding ≤ 1μM |
| CCNB_MARGL | P15206 | G2/mitotic-specific Cyclin B, Margl | 400 | 0.32 | Binding ≤ 1μM |
| CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 210 | 0.33 | Binding ≤ 1μM |
| CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 210 | 0.33 | Binding ≤ 1μM |
| CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 210 | 0.33 | Binding ≤ 1μM |
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 280 | 0.33 | Binding ≤ 1μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 280 | 0.33 | Binding ≤ 1μM |
| MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 330 | 0.32 | Binding ≤ 1μM |
| MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 620 | 0.31 | Binding ≤ 1μM |
| PYGM_HUMAN | P11217 | Muscle Glycogen Phosphorylase, Human | 1000 | 0.30 | Binding ≤ 1μM |
| DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 650 | 0.31 | Binding ≤ 1μM |
| KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 590 | 0.31 | Binding ≤ 1μM |
| KPCE_HUMAN | Q02156 | Protein Kinase C Epsilon, Human | 380 | 0.32 | Binding ≤ 1μM |
| KPCL_HUMAN | P24723 | Protein Kinase C Eta, Human | 350 | 0.32 | Binding ≤ 1μM |
| KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 520 | 0.31 | Binding ≤ 1μM |
| KPCD3_HUMAN | O94806 | Protein Kinase C Nu, Human | 170 | 0.34 | Binding ≤ 1μM |
| KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 350 | 0.32 | Binding ≤ 1μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 720 | 0.31 | Binding ≤ 1μM |
| KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 800 | 0.30 | Binding ≤ 1μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 370 | 0.32 | Binding ≤ 1μM |
| CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 180 | 0.34 | Binding ≤ 1μM |
| CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 480 | 0.32 | Binding ≤ 1μM |
| CDK14_HUMAN | O94921 | Serine/threonine-protein Kinase PFTAIRE-1, Human | 110 | 0.35 | Binding ≤ 1μM |
| PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 520 | 0.31 | Binding ≤ 1μM |
| PIM2_HUMAN | Q9P1W9 | Serine/threonine-protein Kinase PIM2, Human | 650 | 0.31 | Binding ≤ 1μM |
| PIM3_HUMAN | Q86V86 | Serine/threonine-protein Kinase PIM3, Human | 600 | 0.31 | Binding ≤ 1μM |
| TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 55 | 0.36 | Binding ≤ 1μM |
| ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 1900 | 0.29 | Binding ≤ 10μM |
| AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 2400 | 0.28 | Binding ≤ 10μM |
| AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 5300 | 0.26 | Binding ≤ 10μM |
| ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 670 | 0.31 | Binding ≤ 10μM |
| AAPK1_HUMAN | Q13131 | AMP-activated Protein Kinase, Alpha-1 Subunit, Human | 6600 | 0.26 | Binding ≤ 10μM |
| MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 5500 | 0.26 | Binding ≤ 10μM |
| KCC2A_HUMAN | Q9UQM7 | CaM Kinase II Alpha, Human | 1300 | 0.29 | Binding ≤ 10μM |
| KCC2B_HUMAN | Q13554 | CaM Kinase II Beta, Human | 2600 | 0.28 | Binding ≤ 10μM |
| KCC4_HUMAN | Q16566 | CaM Kinase IV, Human | 3200 | 0.27 | Binding ≤ 10μM |
| KKCC1_HUMAN | Q8N5S9 | CaM-kinase Kinase Alpha, Human | 19 | 0.39 | Binding ≤ 10μM |
| KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 320 | 0.32 | Binding ≤ 10μM |
| CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 57 | 0.36 | Binding ≤ 10μM |
| CDK8_HUMAN | P49336 | Cell Division Protein Kinase 8, Human | 120 | 0.35 | Binding ≤ 10μM |
| CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 110 | 0.35 | Binding ≤ 10μM |
| CCNA1_HUMAN | P78396 | Cyclin A1, Human | 1500 | 0.29 | Binding ≤ 10μM |
| CCNA2_HUMAN | P20248 | Cyclin A2, Human | 1500 | 0.29 | Binding ≤ 10μM |
| CCNH_HUMAN | P51946 | Cyclin H, Human | 400 | 0.32 | Binding ≤ 10μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 210 | 0.33 | Binding ≤ 10μM |
| Z104296 | Z104296 | Cyclin-dependent Kinase 1/cyclin B1 | 200 | 0.33 | Binding ≤ 10μM |
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 1500 | 0.29 | Binding ≤ 10μM |
| CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 410 | 0.32 | Binding ≤ 10μM |
| CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 100 | 0.35 | Binding ≤ 10μM |
| Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 100 | 0.35 | Binding ≤ 10μM |
| CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 110 | 0.35 | Binding ≤ 10μM |
| Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 170 | 0.34 | Binding ≤ 10μM |
| CDK6_HUMAN | Q00534 | Cyclin-dependent Kinase 6, Human | 80 | 0.35 | Binding ≤ 10μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 23 | 0.38 | Binding ≤ 10μM |
| CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 20 | 0.38 | Binding ≤ 10μM |
| CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 1400 | 0.29 | Binding ≤ 10μM |
| CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 1000 | 0.30 | Binding ≤ 10μM |
| DYR1B_HUMAN | Q9Y463 | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B, Human | 84 | 0.35 | Binding ≤ 10μM |
| CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 1700 | 0.29 | Binding ≤ 10μM |
| EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 2500 | 0.28 | Binding ≤ 10μM |
| EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 3300 | 0.27 | Binding ≤ 10μM |
| EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 4000 | 0.27 | Binding ≤ 10μM |
| EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 2200 | 0.28 | Binding ≤ 10μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1400 | 0.29 | Binding ≤ 10μM |
| CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 100 | 0.35 | Binding ≤ 10μM |
| CCND2_HUMAN | P30279 | G1/S-specific Cyclin D2, Human | 100 | 0.35 | Binding ≤ 10μM |
| CCND3_HUMAN | P30281 | G1/S-specific Cyclin D3, Human | 100 | 0.35 | Binding ≤ 10μM |
| CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 170 | 0.34 | Binding ≤ 10μM |
| CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 170 | 0.34 | Binding ≤ 10μM |
| CCNB_MARGL | P15206 | G2/mitotic-specific Cyclin B, Margl | 400 | 0.32 | Binding ≤ 10μM |
| CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 210 | 0.33 | Binding ≤ 10μM |
| CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 210 | 0.33 | Binding ≤ 10μM |
| CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 210 | 0.33 | Binding ≤ 10μM |
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 280 | 0.33 | Binding ≤ 10μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 280 | 0.33 | Binding ≤ 10μM |
| IKKE_HUMAN | Q14164 | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit, Human | 3100 | 0.28 | Binding ≤ 10μM |
| E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 5200 | 0.26 | Binding ≤ 10μM |
| LTK_HUMAN | P29376 | Leukocyte Tyrosine Kinase Receptor, Human | 2200 | 0.28 | Binding ≤ 10μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 2800 | 0.28 | Binding ≤ 10μM |
| MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 1900 | 0.29 | Binding ≤ 10μM |
| MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 330 | 0.32 | Binding ≤ 10μM |
| MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 620 | 0.31 | Binding ≤ 10μM |
| M3K10_HUMAN | Q02779 | Mitogen-activated Protein Kinase Kinase Kinase 10, Human | 5200 | 0.26 | Binding ≤ 10μM |
| M3K9_HUMAN | P80192 | Mitogen-activated Protein Kinase Kinase Kinase 9, Human | 5700 | 0.26 | Binding ≤ 10μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 3300 | 0.27 | Binding ≤ 10μM |
| M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 4500 | 0.27 | Binding ≤ 10μM |
| PYGM_HUMAN | P11217 | Muscle Glycogen Phosphorylase, Human | 1000 | 0.30 | Binding ≤ 10μM |
| DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 650 | 0.31 | Binding ≤ 10μM |
| NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 1400 | 0.29 | Binding ≤ 10μM |
| PHKG1_HUMAN | Q16816 | Phosphorylase Kinase Gamma Subunit 1, Human | 2200 | 0.28 | Binding ≤ 10μM |
| PHKG2_HUMAN | P15735 | Phosphorylase Kinase Gamma Subunit 2, Human | 2000 | 0.28 | Binding ≤ 10μM |
| KPCA_HUMAN | P17252 | Protein Kinase C Alpha, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCE_HUMAN | Q02156 | Protein Kinase C Epsilon, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCL_HUMAN | P24723 | Protein Kinase C Eta, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCG_HUMAN | P05129 | Protein Kinase C Gamma, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCI_HUMAN | P41743 | Protein Kinase C Iota, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCD3_HUMAN | O94806 | Protein Kinase C Nu, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 10000 | 0.25 | Binding ≤ 10μM |
| KPCZ_HUMAN | Q05513 | Protein Kinase C Zeta, Human | 10000 | 0.25 | Binding ≤ 10μM |
| PKN1_HUMAN | Q16512 | Protein Kinase N1, Human | 3500 | 0.27 | Binding ≤ 10μM |
| MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 6800 | 0.26 | Binding ≤ 10μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 2300 | 0.28 | Binding ≤ 10μM |
| KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 1500 | 0.29 | Binding ≤ 10μM |
| KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 1300 | 0.29 | Binding ≤ 10μM |
| KS6A5_HUMAN | O75582 | Ribosomal Protein S6 Kinase Alpha 5, Human | 2000 | 0.28 | Binding ≤ 10μM |
| KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 800 | 0.30 | Binding ≤ 10μM |
| ST17B_HUMAN | O94768 | Serine/threonine-protein Kinase 17B, Human | 1900 | 0.29 | Binding ≤ 10μM |
| STK33_HUMAN | Q9BYT3 | Serine/threonine-protein Kinase 33, Human | 1700 | 0.29 | Binding ≤ 10μM |
| KPCD2_HUMAN | Q9BZL6 | Serine/threonine-protein Kinase D2, Human | 1100 | 0.30 | Binding ≤ 10μM |
| DCLK1_HUMAN | O15075 | Serine/threonine-protein Kinase DCLK1, Human | 2100 | 0.28 | Binding ≤ 10μM |
| DCLK3_HUMAN | Q9C098 | Serine/threonine-protein Kinase DCLK3, Human | 1100 | 0.30 | Binding ≤ 10μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 1100 | 0.30 | Binding ≤ 10μM |
| MRCKB_HUMAN | Q9Y5S2 | Serine/threonine-protein Kinase MRCK Beta, Human | 3300 | 0.27 | Binding ≤ 10μM |
| MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 9500 | 0.25 | Binding ≤ 10μM |
| STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 9400 | 0.25 | Binding ≤ 10μM |
| CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 180 | 0.34 | Binding ≤ 10μM |
| CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 480 | 0.32 | Binding ≤ 10μM |
| CDK18_HUMAN | Q07002 | Serine/threonine-protein Kinase PCTAIRE-3, Human | 1100 | 0.30 | Binding ≤ 10μM |
| CDK14_HUMAN | O94921 | Serine/threonine-protein Kinase PFTAIRE-1, Human | 110 | 0.35 | Binding ≤ 10μM |
| PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 520 | 0.31 | Binding ≤ 10μM |
| PIM2_HUMAN | Q9P1W9 | Serine/threonine-protein Kinase PIM2, Human | 650 | 0.31 | Binding ≤ 10μM |
| PIM3_HUMAN | Q86V86 | Serine/threonine-protein Kinase PIM3, Human | 600 | 0.31 | Binding ≤ 10μM |
| PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 3100 | 0.28 | Binding ≤ 10μM |
| TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 55 | 0.36 | Binding ≤ 10μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 4600 | 0.27 | Binding ≤ 10μM |
| TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 5600 | 0.26 | Binding ≤ 10μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 3200 | 0.27 | Binding ≤ 10μM |
| UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 3500 | 0.27 | Binding ≤ 10μM |
| SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 1400 | 0.29 | Binding ≤ 10μM |
| Z80852 | Z80852 | A-431 (Epidermoid Carcinoma Cells) | 75 | 0.36 | Functional ≤ 10μM |
| Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 38 | 0.37 | Functional ≤ 10μM |
| Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 96 | 0.35 | Functional ≤ 10μM |
| Z100090 | Z100090 | ABAE (Fibroblast Cells) | 45 | 0.37 | Functional ≤ 10μM |
| Z80675 | Z80675 | AG1523 (Fibroblast Cells) | 6700 | 0.26 | Functional ≤ 10μM |
| Z80054 | Z80054 | Caco-2 (Colon Adenocarcinoma Cells) | 86 | 0.35 | Functional ≤ 10μM |
| Z80064 | Z80064 | CCRF-CEM (T-cell Leukemia) | 52 | 0.36 | Functional ≤ 10μM |
| Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 17 | 0.39 | Functional ≤ 10μM |
| Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 46 | 0.37 | Functional ≤ 10μM |
| Z100091 | Z100091 | HS27 (Fibroblast Cells) | 51 | 0.36 | Functional ≤ 10μM |
| Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 130 | 0.34 | Functional ≤ 10μM |
| Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 16 | 0.39 | Functional ≤ 10μM |
| Z81186 | Z81186 | LS174T (Colon Adencocarcinoma Cells) | 65 | 0.36 | Functional ≤ 10μM |
| Z100093 | Z100093 | LX-1 (Lung Carcinoma Cells) | 75 | 0.36 | Functional ≤ 10μM |
| Z81225 | Z81225 | M109 (Lung Carcinoma Cells) | 80 | 0.35 | Functional ≤ 10μM |
| Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 26 | 0.38 | Functional ≤ 10μM |
| Z100095 | Z100095 | MIP (Colon Carcinoma Cells) | 120 | 0.35 | Functional ≤ 10μM |
| Z100094 | Z100094 | MLF (Lung Fibroblast Cells) | 72 | 0.36 | Functional ≤ 10μM |
| Z80354 | Z80354 | OVCAR-3 (Ovarian Adenocarcinoma Cells) | 54 | 0.36 | Functional ≤ 10μM |
| Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 10000 | 0.25 | Functional ≤ 10μM |
| Z80475 | Z80475 | SK-BR-3 (Breast Adenocarcinoma) | 77 | 0.36 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Acetylcholine regulates insulin secretion | |
| Activation of ATR in response to replication stress | |
| Activation of CaMK IV | |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |
| Activation of NF-kappaB in B cells | |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| Activation of the AP-1 family of transcription factors | |
| Activation of the pre-replicative complex | |
| AKT phosphorylates targets in the cytosol | |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
| APC truncation mutants have impaired AXIN binding | |
| APC/C:Cdc20 mediated degradation of Cyclin B | |
| Apoptotic cleavage of cellular proteins | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| Ca2+ pathway | |
| Calmodulin induced events | |
| CaMK IV-mediated phosphorylation of CREB | |
| CDK-mediated phosphorylation and removal of Cdc6 | |
| Cell surface interactions at the vascular wall | |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
| Condensation of Prometaphase Chromosomes | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
| CREB phosphorylation | |
| CREB phosphorylation through the activation of CaMKII | |
| CREB phosphorylation through the activation of CaMKK | |
| CREB phosphorylation through the activation of Ras | |
| CRMPs in Sema3A signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin B2 mediated events | |
| Cyclin D associated events in G1 | |
| Cyclin E associated events during G1/S transition | |
| DAG and IP3 signaling | |
| DARPP-32 events | |
| Degradation of beta-catenin by the destruction complex | |
| Depolymerisation of the Nuclear Lamina | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| Disinhibition of SNARE formation | |
| DNA Damage/Telomere Stress Induced Senescence | |
| Downregulation of TGF-beta receptor signaling | |
| Downstream TCR signaling | |
| Dual incision reaction in GG-NER | |
| Dual incision reaction in TC-NER | |
| E2F mediated regulation of DNA replication | |
| E2F-enabled inhibition of pre-replication complex formation | |
| Effects of PIP2 hydrolysis | |
| EGFR downregulation | |
| EGFR interacts with phospholipase C-gamma | |
| EGFR Transactivation by Gastrin | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| Ephrin signaling | |
| ERK/MAPK targets | |
| ERK1 activation | |
| ERKs are inactivated | |
| Factors involved in megakaryocyte development and platelet production | |
| FCERI mediated MAPK activation | |
| FCERI mediated NF-kB activation | |
| Formation of HIV elongation complex in the absence of HIV Tat | |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | |
| Formation of incision complex in GG-NER | |
| Formation of RNA Pol II elongation complex | |
| Formation of the Early Elongation Complex | |
| Formation of the HIV-1 Early Elongation Complex | |
| Formation of transcription-coupled NER (TC-NER) repair complex | |
| G alpha (z) signalling events | |
| G0 and Early G1 | |
| G1/S-Specific Transcription | |
| G2 Phase | |
| G2/M DNA replication checkpoint | |
| GAB1 signalosome | |
| Gastrin-CREB signalling pathway via PKC and MAPK | |
| Generic Transcription Pathway | |
| Glycogen breakdown (glycogenolysis) | |
| Golgi Associated Vesicle Biogenesis | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| GPVI-mediated activation cascade | |
| GRB2 events in EGFR signaling | |
| GRB2 events in ERBB2 signaling | |
| HIV elongation arrest and recovery | |
| HIV Transcription Initiation | |
| HSF1-dependent transactivation | |
| HuR stabilizes mRNA | |
| Inactivation, recovery and regulation of the phototransduction cascade | |
| Inhibition of PKR | |
| Interactions of Tat with host cellular proteins | |
| Interferon gamma signaling | |
| ISG15 antiviral mechanism | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MASTL Facilitates Mitotic Progression | |
| Meiotic recombination | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| mRNA Capping | |
| NCAM signaling for neurite out-growth | |
| Negative regulators of RIG-I/MDA5 signaling | |
| Netrin-1 signaling | |
| NoRC negatively regulates rRNA expression | |
| NOTCH1 Intracellular Domain Regulates Transcription | |
| Nuclear Pore Complex (NPC) Disassembly | |
| Oncogene Induced Senescence | |
| Orc1 removal from chromatin | |
| Oxidative Stress Induced Senescence | |
| p53-Dependent G1 DNA Damage Response | |
| p75NTR recruits signalling complexes | |
| Pausing and recovery of HIV elongation | |
| Pausing and recovery of Tat-mediated HIV elongation | |
| Phosphorylation of Emi1 | |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
| Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
| Phosphorylation of the APC/C | |
| PI3K events in ERBB2 signaling | |
| PIP3 activates AKT signaling | |
| PLCG1 events in ERBB2 signaling | |
| Polo-like kinase mediated events | |
| PPARA activates gene expression | |
| Pre-NOTCH Transcription and Translation | |
| Ras activation uopn Ca2+ infux through NMDA receptor | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recruitment of NuMA to mitotic centrosomes | |
| Recycling pathway of L1 | |
| Regulation of AMPK activity via LKB1 | |
| Regulation of APC/C activators between G1/S and early anaphase | |
| Regulation of HSF1-mediated heat shock response | |
| Regulation of KIT signaling | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of Rheb GTPase activity by AMPK | |
| Regulation of signaling by NODAL | |
| Resolution of Sister Chromatid Cohesion | |
| Response to elevated platelet cytosolic Ca2+ | |
| RMTs methylate histone arginines | |
| RNA Pol II CTD phosphorylation and interaction with CE | |
| RNA Polymerase I Chain Elongation | |
| RNA Polymerase I Promoter Escape | |
| RNA Polymerase I Transcription Initiation | |
| RNA Polymerase I Transcription Termination | |
| RNA Polymerase II HIV Promoter Escape | |
| RNA Polymerase II Pre-transcription Events | |
| RNA Polymerase II Promoter Escape | |
| RNA Polymerase II Transcription Elongation | |
| RNA Polymerase II Transcription Initiation | |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
| Role of phospholipids in phagocytosis | |
| RSK activation | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| SCF(Skp2)-mediated degradation of p27/p21 | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| SHC1 events in EGFR signaling | |
| SHC1 events in ERBB2 signaling | |
| Signal transduction by L1 | |
| Signaling by Activin | |
| Signaling by BMP | |
| Signaling by constitutively active EGFR | |
| Signaling by EGFR | |
| Signaling by ERBB2 | |
| Signaling by ERBB4 | |
| Signaling by Hippo | |
| Signaling by NODAL | |
| Signaling by SCF-KIT | |
| Signalling to ERK5 | |
| SMAD2/3 MH2 Domain Mutants in Cancer | |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
| Sphingolipid de novo biosynthesis | |
| Syndecan interactions | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| Tat-mediated elongation of the HIV-1 transcript | |
| Tat-mediated HIV elongation arrest and recovery | |
| TGF-beta receptor signaling activates SMADs | |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
| TGFBR1 KD Mutants in Cancer | |
| TGFBR1 LBD Mutants in Cancer | |
| TGFBR2 Kinase Domain Mutants in Cancer | |
| TGFBR2 MSI Frameshift Mutants in Cancer | |
| Tight junction interactions | |
| TRAF3-dependent IRF activation pathway | |
| TRAF6 mediated IRF7 activation | |
| Trafficking of AMPA receptors | |
| Trafficking of GluR2-containing AMPA receptors | |
| Transcription of the HIV genome | |
| Transcriptional activation of mitochondrial biogenesis | |
| Transcriptional regulation of white adipocyte differentiation | |
| truncations of AMER1 destabilize the destruction complex | |
| Ubiquitin-dependent degradation of Cyclin D1 | |
| Unblocking of NMDA receptor, glutamate binding and activation | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation | |
| WNT5A-dependent internalization of FZD4 | |
| XBP1(S) activates chaperone genes |